Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - INTEREST INCOME & EXPENSE
Interest Income & Expense ESPR - Esperion Therapeutics, Inc.
59 M
LAST VALUE
12.80%
2 YEAR CAGR
258.21%
5 YEAR CAGR
51.33%
10 YEAR CAGR